Literature DB >> 16764782

Do we need alternative treatment options for autoimmune hepatitis?

Antal Csepregi1, Peter Malfertheiner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16764782     DOI： 10.1007/s11894-006-0069-6

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN： 1522-8037


× No keyword cloud information.
  17 in total

Review 1.  Autoimmune hepatitis: clinical challenges.

Authors:  M P Manns; C P Strassburg
Journal:  Gastroenterology       Date:  2001-05       Impact factor: 22.682

2.  Diagnosis and treatment of autoimmune hepatitis.

Authors:  Albert J Czaja; Deborah K Freese
Journal:  Hepatology       Date:  2002-08       Impact factor: 17.425

3.  Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared.

Authors:  W H Summerskill; M G Korman; H V Ammon; A H Baggenstoss
Journal:  Gut       Date:  1975-11       Impact factor: 23.059

4.  Effects of ursodeoxycholic acid on serum liver enzymes and bile acid metabolism in chronic active hepatitis: a dose-response study.

Authors:  A Crosignani; P M Battezzati; K D Setchell; M Camisasca; E Bertolini; A Roda; M Zuin; M Podda
Journal:  Hepatology       Date:  1991-02       Impact factor: 17.425

5.  Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine.

Authors:  P D Richardson; P D James; S D Ryder
Journal:  J Hepatol       Date:  2000-09       Impact factor: 25.083

Review 6.  Treatment challenges and investigational opportunities in autoimmune hepatitis.

Authors:  Albert J Czaja; Francesco B Bianchi; Herschel A Carpenter; Edward L Krawitt; Ansgar W Lohse; Michael P Manns; Ian G McFarlane; Giorgina Mieli-Vergani; Gotaro Toda; Diego Vergani; John Vierling; Mikio Zeniya
Journal:  Hepatology       Date:  2005-01       Impact factor: 17.425

7.  Oral budesonide for treatment of autoimmune chronic active hepatitis.

Authors:  A Danielsson; H Prytz
Journal:  Aliment Pharmacol Ther       Date:  1994-12       Impact factor: 8.171

8.  Efficacy of ursodeoxycholic acid in Japanese patients with type 1 autoimmune hepatitis.

Authors:  K Nakamura; M Yoneda; S Yokohama; K Tamori; Y Sato; K Aso; M Aoshima; T Hasegawa; I Makino
Journal:  J Gastroenterol Hepatol       Date:  1998-05       Impact factor: 4.029

9.  Budesonide induces complete remission in autoimmune hepatitis.

Authors:  Antal Csepregi; Christoph Röcken; Gerhard Treiber; Peter Malfertheiner
Journal:  World J Gastroenterol       Date:  2006-03-07       Impact factor: 5.742

10.  Prognosis of histological cirrhosis in type 1 autoimmune hepatitis.

Authors:  S K Roberts; T M Therneau; A J Czaja
Journal:  Gastroenterology       Date:  1996-03       Impact factor: 22.682
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.